Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘gastrointestinal cancer’

October 4, 2019

Chemo first for better outcomes in bile duct cancer, says new research

By Elizabeth Zimmermann Elizabeth Zimmermann

Oncology care teams frequently use chemotherapy along with surgery to treat cholangiocarcinoma, or bile duct cancer. However, until now, little evidence existed regarding if and when receiving chemotherapy was likely to have the best effect. Recently Mayo Clinic researchers found that patients who received chemotherapy before surgery to remove their bile duct cancer were more […]

View full entry

Tags: Amit Mahipal, bile ducts, cancer, Center for the Science of Health Care Delivery, chemotherapy, cholangiocarcinoma, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center, oncology, rare disease, Siddhartha Yadav


July 31, 2019

Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment

By Advancing the Science contributor Advancing the Science contributor

By Sharon Rosen Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and […]

View full entry

Tags: breast cancer, cancer, Center for Individualized Medicine, gastrointestinal cancer, genetic testing, hereditary cancer, Mayo Clinic Cancer Center, Mayo Clinic Proceedings, Niloy "Jewel" Samadder, ovarian cancer


October 3, 2018

Mayo Clinic Awarded Nation’s First Hepatobiliary SPORE Grant

By Nicole Ferrara Nicole Ferrara

The National Cancer Institute (NCI) has awarded Mayo Clinic an $11.5 million grant to fund  a Specialized Program of Research Excellence (SPORE) in hepatobiliary cancer through August 2023. Headed by principal investigators Mark A. McNiven, Ph.D., and Lewis R. Roberts, M.B., Ch.B., Ph.D., the goal of the Mayo Clinic Hepatobiliary SPORE is to make discoveries […]

View full entry

Tags: cancer, Chen Wang, Edward Leof, gastrointestinal cancer, Gregory Gores, John Copland III, Lewis Roberts, liver cancer, Mark McNiven, Mark Truty, Mayo Clinic Cancer Center, Michael Torbenson


Contact Us · Privacy Policy